<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
<TABLE>
<S> <C>
Date of Report: December 13, 1999
---------------------
Date of Earliest
Event Reported: December 10, 1999
---------------------
</TABLE>
BERKSHIRE BANCORP INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Delaware 0-13649 94-2563513
- ---------------------------- ----------- ----------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
160 Broadway, New York, New York 10038
------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
</TABLE>
Registrant's telephone number, including area code: (212)791-5362
Cooper Life Sciences, Inc.
---------------------------------------------------------
Former name or former address, if changed since last report
<PAGE>
Item 8. Change in Fiscal Year
On December 10, 1999, the Board of Directors of Berkshire Bancorp Inc.
(the "Company"), approved a change in the Company's fiscal year to December 31.
The report covering the two month transition period ending December 31, 1999
will be filed on Form 10-K.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BERKSHIRE BANCORP INC.
-----------------------------
(Registrant)
Date: December 13, 1999 By: /s/ Steven Rosenberg
--------------------- -----------------------
Steven Rosenberg
President and Chief
Financial Officer
3
